Literature DB >> 370089

Differential inhibition of bacterial growth and hemolysin production by lincosamide antibiotics.

A M Shibl, I A Al-Sowaygh.   

Abstract

Lincomycin and clindamycin, at concentrations below those which partially inhibited bacterial growth, completely suppressed the production of streptolysin S. Chloramphenicol and erythromycin had no effect on hemolysin production.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 370089      PMCID： PMC218390          DOI： 10.1128/jb.137.2.1022-1023.1979

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  2 in total

Review 1.  Production of extracellular proteins by bacteria.

Authors:  A R Glenn
Journal:  Annu Rev Microbiol       Date:  1976       Impact factor: 15.500

2.  Effects of streptomycin and novobiocin on Staphylococcus aureus gene expression.

Authors:  K Nordström; M Lindberg
Journal:  J Bacteriol       Date:  1978-02       Impact factor: 3.490
  2 in total
  4 in total

1.  Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus.

Authors:  S Herbert; P Barry; R P Novick
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 2.  Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.

Authors:  Roland Nau; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

3.  Effect of subminimal inhibitory concentrations of antimicrobial agents on the piliation and adherence of Neisseria meningitidis.

Authors:  B E Kristiansen; L Rustad; O Spanne; B Bjorvatn
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

4.  Influence of clindamycin on derepression of beta-lactamases in Enterobacter spp. and Pseudomonas aeruginosa.

Authors:  C C Sanders; W E Sanders; R V Goering
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.